- Home
- Publications
- Publication Search
- Publication Details
Title
Genetic predisposition to prostate cancer: an update
Authors
Keywords
-
Journal
Familial Cancer
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-01-24
DOI
10.1007/s10689-021-00227-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BARCODE 1: A pilot study investigating the use of genetic profiling to identify men in the general population with the highest risk of prostate cancer to invite for targeted screening.
- (2020) Ros A. Eeles et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
- (2020) Mary B. Daly et al. Journal of the National Comprehensive Cancer Network
- Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) C. Parker et al. ANNALS OF ONCOLOGY
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
- (2020) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival outcomes in men with a positive family history of prostate cancer: a registry based study
- (2020) Mann Ang et al. BMC CANCER
- PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer
- (2019) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines
- (2019) Piper Nicolosi et al. JAMA Oncology
- Bringing prostate cancer germline genetics into clinical practice
- (2019) Sanjay Das et al. JOURNAL OF UROLOGY
- Genetic testing for hereditary prostate cancer among men in Israel
- (2019) S. Golan et al. EUROPEAN UROLOGY SUPPLEMENTS
- Prostate Cancer Incidence and Mortality in Relationship to Family History of Prostate Cancer; Findings from The PLCO Trial.
- (2019) Omar Abdel-Rahman Clinical Genitourinary Cancer
- Platinum-based chemotherapy in metastatic prostate cancer with alterations in DNA damage repair genes.
- (2019) Jose Mauricio Mota et al. JOURNAL OF CLINICAL ONCOLOGY
- Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI
- (2019) Tobias Nordström et al. BMJ Open
- Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
- (2019) Tommy Nyberg et al. EUROPEAN UROLOGY
- Polygenic risk-tailored screening for prostate cancer: A benefit–harm and cost-effectiveness modelling study
- (2019) Tom Callender et al. PLOS MEDICINE
- A Review of Prostate Cancer Genome-Wide Association Studies (GWAS)
- (2018) Sarah Benafif et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
- (2018) Veda N. Giri et al. JOURNAL OF CLINICAL ONCOLOGY
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- Malignant Abnormalities in Male BRCA Mutation Carriers
- (2018) Roy Mano et al. JAMA Oncology
- The GENTleMEN study: Genetic testing for men with metastatic prostate cancer in Washington state and beyond.
- (2018) Heather H. Cheng et al. JOURNAL OF CLINICAL ONCOLOGY
- Genomic Analysis of Three Metastatic Prostate Cancer Patients with Exceptional Responses to Carboplatin Indicating Different Types of DNA Repair Deficiency
- (2018) Zafeiris Zafeiriou et al. EUROPEAN UROLOGY
- Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
- (2018) H. Ballentine Carter et al. EUROPEAN UROLOGY
- Homeobox B13 G84E Mutation and Prostate Cancer Risk
- (2018) Tommy Nyberg et al. EUROPEAN UROLOGY
- Inherited NBN Mutations and Prostate Cancer Risk and Survival
- (2018) Bogna Rusak et al. Cancer Research and Treatment
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores
- (2017) Julie Lecarpentier et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
- (2017) Hashim U Ahmed et al. LANCET
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer
- (2016) Elena Castro et al. ONCOLOGIST
- A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)
- (2015) Marco Randazzo et al. BJU INTERNATIONAL
- Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
- (2015) Elena Castro et al. EUROPEAN UROLOGY
- Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
- (2015) Nora Pashayan et al. GENETICS IN MEDICINE
- Impact of Family History on Prostate Cancer Mortality in White Men Undergoing Prostate Specific Antigen Based Screening
- (2015) Michael A. Liss et al. JOURNAL OF UROLOGY
- Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study
- (2015) Henrik Grönberg et al. LANCET ONCOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
- (2014) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
- (2014) J. B. Hjelmborg et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
- (2013) V. H. Laitinen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Positive Family History of Prostate Cancer Increase the Risk of Prostate Cancer on Initial Prostate Biopsy?
- (2013) Ahmed Elshafei et al. UROLOGY
- An inherited NBN mutation is associated with poor prognosis prostate cancer
- (2012) C Cybulski et al. BRITISH JOURNAL OF CANCER
- Potential Impact of Adding Genetic Markers to Clinical Parameters in Predicting Prostate Biopsy Outcomes in Men Following an Initial Negative Biopsy: Findings from the REDUCE Trial
- (2012) A. Karim Kader et al. EUROPEAN UROLOGY
- A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
- (2012) Robert Karlsson et al. EUROPEAN UROLOGY
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk for incident and fatal prostate cancer in men with a family history of any incident and fatal cancer
- (2011) A. Brandt et al. ANNALS OF ONCOLOGY
- Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study
- (2010) Anita V. Mitra et al. BJU INTERNATIONAL
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- 960 THE INFLUENCE OF A POSITIVE FAMILY HISTORY ON PROSTATE CANCER INCIDENCE AND DUTASTERIDE EFFICACY IN THE REDUCE STUDY
- (2010) T.L.J. Tammela et al. EUROPEAN UROLOGY SUPPLEMENTS
- Risk Stratification and Validation of Prostate Specific Antigen Density as Independent Predictor of Progression in Men With Low Risk Prostate Cancer During Active Surveillance
- (2010) Ignacio F. San Francisco et al. JOURNAL OF UROLOGY
- Effect of Dutasteride on the Risk of Prostate Cancer
- (2010) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- Finding the missing heritability of complex diseases
- (2009) Teri A. Manolio et al. NATURE
- Estimation of absolute risk for prostate cancer using genetic markers and family history
- (2009) Jianfeng Xu et al. PROSTATE
- Multiple Novel Prostate Cancer Predisposition Loci Confirmed by an International Study: The PRACTICAL Consortium
- (2008) Z. Kote-Jarai et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multiple newly identified loci associated with prostate cancer susceptibility
- (2008) Rosalind A Eeles et al. NATURE GENETICS
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now